Clinical Trial Update: Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19

View source ↗

Summary

A completed clinical trial evaluating myocardial injury and major adverse outcomes in patients with COVID-19, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Myocardial Reperfusion Injury

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: COVID-19, Myocardial Reperfusion Injury | Status: COMPLETED | Results posted: 2024-03-08